DNAJB6P5

Across TCGA pan-cancer cohorts, DNAJB6P5 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated DNAJB6P5 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher DNAJB6P5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DNAJB6P5 expression acts as an unfavorable survival marker.

KIRC, CESC, and UVM are the cancer types where DNAJB6P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	III,IV	0.311	0.498	.013	69	view →
CESC	OS	Tertile	IV	0.167	0.612	.008	36	view →
UVM	DFS	Tertile	All	0.079	0.746	<.001	27	view →
LUSC	OS	Tertile	II,III,IV	0.628	0.756	.023	18	view →
KIRP	OS	Tertile	All	0.704	0.907	.016	9	view →
SARC	OS	Tertile	All	0.253	0.625	.004	9	view →
LGG	OS	Tertile	All	0.240	0.474	.028	6	view →
TGCT	DFS	Tertile	All	0.631	0.820	.033	6	view →
ESCA	OS	Median	II,III,IV	0.430	0.589	.022	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

DNAJB6P5–KIRC (DFS)

Open the KIRC breakdown →